Literature DB >> 16531963

Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction.

Rodrigo Torres-Baranda1, Blanca E Bastidas-Ramírez, Montserrat Maldonado-González, Laura V Sánchez-Orozco, Eduardo Vázquez-Vals, Eduardo Rodríguez-Noriega, Arturo Panduro.   

Abstract

Hepatitis B virus infection (HBV) with undetectable levels of HBsAg, has been named occult HBV infection and observed in immunosuppressed patients. The aim of this study was to determine the frequency of occult HBV infection in patients with HIV from the West of México, using a combination of serological markers and nPCR. Thirty eight HIV/AIDS patients, 32 men (84.2%) and 6 (5.8%) women, without liver damage related symptoms were studied. HBV coinfection was observed in 10 (26.3%) patients; while only 3 (7.9%) of them were positive to HBsAg. Thus, 7 (18.4%) occult HBV infected patients could be assessed in this population. One (10%) patient with occult HBV infection was positive to anti-HBs, in spite of the reinfection protection attributed to this serological marker. Anti-HBc was detected only in 2 (20%) patients with occult HBV infection. No significant association could be established between occult HBV infection and CD+4 cell count, biochemical, clinical parameters, AIDS stage, or any other risk factor. This study suggest that determination of HBV DNA utilizing highly sensitive techniques, as nPCR, should be performed to detect occult HBV infection, even in the absence of anti-HBc in HIV/ AIDS patients, in order to have a reliable diagnosis, prevent HBV dissemination and acute exacerbation of chronic hepatitis B or even fulminant hepatitis. To our knowledge this is the first study of occult HBV infection in Mexican patients with HIV. However, further studies are necessary in order to determine HBV genotypes and its relationship with evolution and clinical manifestation of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531963

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

Review 1.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

2.  Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.

Authors:  Stefan Reuter; Mark Oette; Frank Clemens Wilhelm; Bastian Beggel; Rolf Kaiser; Melanie Balduin; Finja Schweitzer; Jens Verheyen; Ortwin Adams; Thomas Lengauer; Gerd Fätkenheuer; Herbert Pfister; Dieter Häussinger
Journal:  Med Microbiol Immunol       Date:  2010-09-19       Impact factor: 3.402

3.  Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject.

Authors:  Arturo Panduro; Sonia Roman; Nora A Fierro; João R Rebello-Pinho
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-03-10

4.  Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.

Authors:  Ma Teresa Alvarez-Muñoz; Angelica Maldonado-Rodriguez; Othon Rojas-Montes; Rocio Torres-Ibarra; Fernanda Gutierrez-Escolano; Guillermo Vazquez-Rosales; Alejandro Gomez; Onofre Muñoz; Javier Torres; Rosalia Lira
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

5.  Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominance.

Authors:  Henry Bautista-Amorocho; Yeny Zulay Castellanos-Domínguez; Laura Andrea Rodríguez-Villamizar; Sindi Alejandra Velandia-Cruz; Jeysson Andrey Becerra-Peña; Ana Elvira Farfán-García
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.